Project
Illumina Body Map 2
Navigation
Downloads
Results for DLX4_HOXD8
Z-value: 2.00
Motif logo
Transcription factors associated with DLX4_HOXD8
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
DLX4
|
ENSG00000108813.9 | distal-less homeobox 4 |
|
HOXD8
|
ENSG00000175879.7 | homeobox D8 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| HOXD8 | hg19_v2_chr2_+_176995011_176995085 | -0.42 | 1.8e-02 | Click! |
| DLX4 | hg19_v2_chr17_+_48046671_48046697 | -0.21 | 2.4e-01 | Click! |
Activity profile of DLX4_HOXD8 motif
Sorted Z-values of DLX4_HOXD8 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_-_158345341 | 11.50 |
ENST00000435117.1
|
CYTIP
|
cytohesin 1 interacting protein |
| chr15_-_22448819 | 9.71 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
| chr17_-_64225508 | 9.21 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
| chr14_+_22337014 | 8.76 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
| chr1_-_183538319 | 8.45 |
ENST00000420553.1
ENST00000419402.1 |
NCF2
|
neutrophil cytosolic factor 2 |
| chr14_+_22580233 | 8.34 |
ENST00000390454.2
|
TRAV25
|
T cell receptor alpha variable 25 |
| chr5_-_55412774 | 8.33 |
ENST00000434982.2
|
ANKRD55
|
ankyrin repeat domain 55 |
| chr10_+_7745303 | 7.88 |
ENST00000429820.1
ENST00000379587.4 |
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
| chr12_-_10151773 | 7.66 |
ENST00000298527.6
ENST00000348658.4 |
CLEC1B
|
C-type lectin domain family 1, member B |
| chr14_+_22631122 | 7.38 |
ENST00000390458.3
|
TRAV29DV5
|
T cell receptor alpha variable 29/delta variable 5 (gene/pseudogene) |
| chr4_+_74275057 | 7.28 |
ENST00000511370.1
|
ALB
|
albumin |
| chr10_+_90521163 | 7.25 |
ENST00000404459.1
|
LIPN
|
lipase, family member N |
| chr15_+_58430567 | 7.21 |
ENST00000536493.1
|
AQP9
|
aquaporin 9 |
| chr21_-_15918618 | 7.19 |
ENST00000400564.1
ENST00000400566.1 |
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1 |
| chr1_-_160492994 | 7.17 |
ENST00000368055.1
ENST00000368057.3 ENST00000368059.3 |
SLAMF6
|
SLAM family member 6 |
| chr5_+_57787254 | 6.84 |
ENST00000502276.1
ENST00000396776.2 ENST00000511930.1 |
GAPT
|
GRB2-binding adaptor protein, transmembrane |
| chr2_-_89399845 | 6.68 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
| chr12_+_9980069 | 6.64 |
ENST00000354855.3
ENST00000324214.4 ENST00000279544.3 |
KLRF1
|
killer cell lectin-like receptor subfamily F, member 1 |
| chr4_+_155484155 | 6.54 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
| chr1_+_196743912 | 6.43 |
ENST00000367425.4
|
CFHR3
|
complement factor H-related 3 |
| chr3_+_108541545 | 6.37 |
ENST00000295756.6
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
| chr12_+_9980113 | 6.26 |
ENST00000537723.1
|
KLRF1
|
killer cell lectin-like receptor subfamily F, member 1 |
| chr4_+_69962212 | 6.09 |
ENST00000508661.1
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr3_+_149192475 | 6.07 |
ENST00000465758.1
|
TM4SF4
|
transmembrane 4 L six family member 4 |
| chr2_-_158345462 | 6.02 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
| chr2_-_89327228 | 6.00 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
| chr12_+_20963632 | 5.99 |
ENST00000540853.1
ENST00000261196.2 |
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
| chr17_-_64216748 | 5.97 |
ENST00000585162.1
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
| chr7_+_142000747 | 5.89 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
| chr12_+_20963647 | 5.83 |
ENST00000381545.3
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
| chr14_-_25078864 | 5.76 |
ENST00000216338.4
ENST00000557220.2 ENST00000382548.4 |
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX) |
| chr4_+_69681710 | 5.74 |
ENST00000265403.7
ENST00000458688.2 |
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
| chr14_-_106494587 | 5.69 |
ENST00000390597.2
|
IGHV2-5
|
immunoglobulin heavy variable 2-5 |
| chr4_+_69962185 | 5.66 |
ENST00000305231.7
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr14_+_22433675 | 5.66 |
ENST00000390442.3
|
TRAV12-3
|
T cell receptor alpha variable 12-3 |
| chr15_+_94899183 | 5.59 |
ENST00000557742.1
|
MCTP2
|
multiple C2 domains, transmembrane 2 |
| chr2_+_90211643 | 5.59 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
| chr14_-_106725723 | 5.49 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr2_-_89513402 | 5.49 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr12_+_113354341 | 5.49 |
ENST00000553152.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
| chr14_-_106471723 | 5.48 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
| chrX_+_78200829 | 5.41 |
ENST00000544091.1
|
P2RY10
|
purinergic receptor P2Y, G-protein coupled, 10 |
| chr15_-_20170354 | 5.39 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
| chr16_+_72090053 | 5.32 |
ENST00000576168.2
ENST00000567185.3 ENST00000567612.2 |
HP
|
haptoglobin |
| chr3_+_108855558 | 5.31 |
ENST00000467240.1
ENST00000477643.1 ENST00000479039.1 ENST00000593799.1 |
RP11-59E19.1
|
RP11-59E19.1 |
| chr13_-_46742630 | 5.24 |
ENST00000416500.1
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
| chr12_+_9822331 | 5.18 |
ENST00000545918.1
ENST00000543300.1 ENST00000261339.6 ENST00000466035.2 |
CLEC2D
|
C-type lectin domain family 2, member D |
| chr11_-_59950486 | 5.15 |
ENST00000426738.2
ENST00000533023.1 ENST00000420732.2 |
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
| chr6_+_161123270 | 5.13 |
ENST00000366924.2
ENST00000308192.9 ENST00000418964.1 |
PLG
|
plasminogen |
| chr1_-_36948879 | 5.13 |
ENST00000373106.1
ENST00000373104.1 ENST00000373103.1 |
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
| chr1_+_81106951 | 5.11 |
ENST00000443565.1
|
RP5-887A10.1
|
RP5-887A10.1 |
| chr4_+_155484103 | 5.08 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
| chr12_+_21284118 | 5.06 |
ENST00000256958.2
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1 |
| chr1_+_196912902 | 5.01 |
ENST00000476712.2
ENST00000367415.5 |
CFHR2
|
complement factor H-related 2 |
| chr1_+_198607801 | 4.92 |
ENST00000367379.1
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
| chr9_-_116837249 | 4.90 |
ENST00000466610.2
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
| chr4_-_69536346 | 4.88 |
ENST00000338206.5
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15 |
| chr2_-_89417335 | 4.86 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chr2_-_89247338 | 4.86 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr14_-_106668095 | 4.83 |
ENST00000390606.2
|
IGHV3-20
|
immunoglobulin heavy variable 3-20 |
| chr7_-_115670792 | 4.79 |
ENST00000265440.7
ENST00000393485.1 |
TFEC
|
transcription factor EC |
| chr4_-_69434245 | 4.75 |
ENST00000317746.2
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17 |
| chr4_-_74853897 | 4.68 |
ENST00000296028.3
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
| chr22_+_22749343 | 4.66 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
| chr14_-_106552755 | 4.62 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
| chr22_+_50981079 | 4.56 |
ENST00000609268.1
|
CTA-384D8.34
|
CTA-384D8.34 |
| chr4_-_155511887 | 4.54 |
ENST00000302053.3
ENST00000403106.3 |
FGA
|
fibrinogen alpha chain |
| chr12_-_10605929 | 4.41 |
ENST00000347831.5
ENST00000359151.3 |
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1 |
| chr6_-_128239749 | 4.37 |
ENST00000537166.1
|
THEMIS
|
thymocyte selection associated |
| chr12_-_10562356 | 4.36 |
ENST00000309384.1
|
KLRC4
|
killer cell lectin-like receptor subfamily C, member 4 |
| chr4_-_39033963 | 4.35 |
ENST00000381938.3
|
TMEM156
|
transmembrane protein 156 |
| chr11_-_59950519 | 4.34 |
ENST00000528851.1
|
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
| chr5_-_135290705 | 4.34 |
ENST00000274507.1
|
LECT2
|
leukocyte cell-derived chemotaxin 2 |
| chr6_-_128239685 | 4.33 |
ENST00000368250.1
|
THEMIS
|
thymocyte selection associated |
| chr10_-_101825151 | 4.32 |
ENST00000441382.1
|
CPN1
|
carboxypeptidase N, polypeptide 1 |
| chr2_-_89340242 | 4.28 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chr7_-_35013217 | 4.28 |
ENST00000446375.1
|
DPY19L1
|
dpy-19-like 1 (C. elegans) |
| chr22_+_23054174 | 4.27 |
ENST00000390308.2
|
IGLV3-21
|
immunoglobulin lambda variable 3-21 |
| chr3_-_42917363 | 4.24 |
ENST00000437102.1
|
CYP8B1
|
cytochrome P450, family 8, subfamily B, polypeptide 1 |
| chr4_+_40198527 | 4.22 |
ENST00000381799.5
|
RHOH
|
ras homolog family member H |
| chr1_+_160709076 | 4.20 |
ENST00000359331.4
ENST00000495334.1 |
SLAMF7
|
SLAM family member 7 |
| chr7_-_115670804 | 4.19 |
ENST00000320239.7
|
TFEC
|
transcription factor EC |
| chr4_-_34271356 | 4.14 |
ENST00000514877.1
|
RP11-548L20.1
|
RP11-548L20.1 |
| chr14_+_22508822 | 4.10 |
ENST00000390448.3
|
TRAV20
|
T cell receptor alpha variable 20 |
| chr10_+_7745232 | 4.09 |
ENST00000358415.4
|
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
| chr16_+_82068585 | 4.09 |
ENST00000563491.1
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
| chr14_-_106453155 | 4.07 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
| chr1_+_160709029 | 4.04 |
ENST00000444090.2
ENST00000441662.2 |
SLAMF7
|
SLAM family member 7 |
| chr1_+_81001398 | 4.02 |
ENST00000418041.1
ENST00000443104.1 |
RP5-887A10.1
|
RP5-887A10.1 |
| chr1_+_198608292 | 3.95 |
ENST00000418674.1
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
| chr4_-_119759795 | 3.95 |
ENST00000419654.2
|
SEC24D
|
SEC24 family member D |
| chr2_+_90273679 | 3.93 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
| chr1_+_160709055 | 3.93 |
ENST00000368043.3
ENST00000368042.3 ENST00000458602.2 ENST00000458104.2 |
SLAMF7
|
SLAM family member 7 |
| chr1_+_57320437 | 3.90 |
ENST00000361249.3
|
C8A
|
complement component 8, alpha polypeptide |
| chr3_+_108541608 | 3.88 |
ENST00000426646.1
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
| chr6_-_133055815 | 3.87 |
ENST00000509351.1
ENST00000417437.2 ENST00000414302.2 ENST00000423615.2 ENST00000427187.2 ENST00000275223.3 ENST00000519686.2 |
VNN3
|
vanin 3 |
| chr12_-_9760482 | 3.85 |
ENST00000229402.3
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1 |
| chr2_+_103035102 | 3.85 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
| chr11_-_59950622 | 3.79 |
ENST00000323961.3
ENST00000412309.2 |
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
| chr7_-_142224280 | 3.78 |
ENST00000390367.3
|
TRBV11-1
|
T cell receptor beta variable 11-1 |
| chr21_+_43823983 | 3.77 |
ENST00000291535.6
ENST00000450356.1 ENST00000319294.6 ENST00000398367.1 |
UBASH3A
|
ubiquitin associated and SH3 domain containing A |
| chr5_+_101569696 | 3.75 |
ENST00000597120.1
|
AC008948.1
|
AC008948.1 |
| chr9_+_95709733 | 3.73 |
ENST00000375482.3
|
FGD3
|
FYVE, RhoGEF and PH domain containing 3 |
| chr22_+_23161491 | 3.73 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 (gene/pseudogene) |
| chr1_+_158801095 | 3.71 |
ENST00000368141.4
|
MNDA
|
myeloid cell nuclear differentiation antigen |
| chr3_-_39321512 | 3.68 |
ENST00000399220.2
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1 |
| chrX_+_78200913 | 3.65 |
ENST00000171757.2
|
P2RY10
|
purinergic receptor P2Y, G-protein coupled, 10 |
| chr1_-_57431679 | 3.64 |
ENST00000371237.4
ENST00000535057.1 ENST00000543257.1 |
C8B
|
complement component 8, beta polypeptide |
| chr14_+_22636283 | 3.63 |
ENST00000557168.1
|
TRAV30
|
T cell receptor alpha variable 30 |
| chr2_-_225811747 | 3.62 |
ENST00000409592.3
|
DOCK10
|
dedicator of cytokinesis 10 |
| chr20_-_7238861 | 3.60 |
ENST00000428954.1
|
RP11-19D2.1
|
RP11-19D2.1 |
| chr4_-_48116540 | 3.58 |
ENST00000506073.1
|
TXK
|
TXK tyrosine kinase |
| chr2_+_234580499 | 3.57 |
ENST00000354728.4
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
| chr6_-_133035185 | 3.56 |
ENST00000367928.4
|
VNN1
|
vanin 1 |
| chr13_+_32313658 | 3.56 |
ENST00000380314.1
ENST00000298386.2 |
RXFP2
|
relaxin/insulin-like family peptide receptor 2 |
| chr4_+_109571740 | 3.56 |
ENST00000361564.4
|
OSTC
|
oligosaccharyltransferase complex subunit (non-catalytic) |
| chr2_+_204801471 | 3.52 |
ENST00000316386.6
ENST00000435193.1 |
ICOS
|
inducible T-cell co-stimulator |
| chr4_+_40201954 | 3.48 |
ENST00000511121.1
|
RHOH
|
ras homolog family member H |
| chr11_+_58695096 | 3.48 |
ENST00000525608.1
ENST00000526351.1 |
GLYATL1
|
glycine-N-acyltransferase-like 1 |
| chr1_+_28199047 | 3.45 |
ENST00000373925.1
ENST00000328928.7 ENST00000373927.3 ENST00000427466.1 ENST00000442118.1 ENST00000373921.3 |
THEMIS2
|
thymocyte selection associated family member 2 |
| chr14_+_22591276 | 3.43 |
ENST00000390455.3
|
TRAV26-1
|
T cell receptor alpha variable 26-1 |
| chr3_+_46412345 | 3.42 |
ENST00000292303.4
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene) |
| chr4_-_69817481 | 3.41 |
ENST00000251566.4
|
UGT2A3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
| chr17_+_34640031 | 3.41 |
ENST00000339270.6
ENST00000482104.1 |
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2 |
| chr2_+_234826016 | 3.41 |
ENST00000324695.4
ENST00000433712.2 |
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8 |
| chr22_+_39966758 | 3.39 |
ENST00000407673.1
ENST00000401624.1 ENST00000404898.1 ENST00000402142.3 ENST00000336649.4 ENST00000400164.3 |
CACNA1I
|
calcium channel, voltage-dependent, T type, alpha 1I subunit |
| chr4_+_74606223 | 3.39 |
ENST00000307407.3
ENST00000401931.1 |
IL8
|
interleukin 8 |
| chr2_+_211342432 | 3.38 |
ENST00000430249.2
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial |
| chr4_+_156824840 | 3.36 |
ENST00000536354.2
|
TDO2
|
tryptophan 2,3-dioxygenase |
| chr14_-_107049312 | 3.34 |
ENST00000390627.2
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
| chr22_+_22516550 | 3.33 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
| chr2_+_90198535 | 3.33 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
| chr2_-_89292422 | 3.30 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chr4_-_38806404 | 3.29 |
ENST00000308979.2
ENST00000505940.1 ENST00000515861.1 |
TLR1
|
toll-like receptor 1 |
| chr4_-_70361579 | 3.29 |
ENST00000512583.1
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4 |
| chr12_-_7656357 | 3.28 |
ENST00000396620.3
ENST00000432237.2 ENST00000359156.4 |
CD163
|
CD163 molecule |
| chr16_+_82068873 | 3.27 |
ENST00000566213.1
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
| chr2_+_234580525 | 3.25 |
ENST00000609637.1
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A8 |
| chr2_-_89161432 | 3.24 |
ENST00000390242.2
|
IGKJ1
|
immunoglobulin kappa joining 1 |
| chr14_+_22392209 | 3.23 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
| chr2_+_234621551 | 3.23 |
ENST00000608381.1
ENST00000373414.3 |
UGT1A1
UGT1A5
|
UDP glucuronosyltransferase 1 family, polypeptide A8 UDP glucuronosyltransferase 1 family, polypeptide A5 |
| chr17_-_29645836 | 3.19 |
ENST00000578584.1
|
CTD-2370N5.3
|
CTD-2370N5.3 |
| chr2_+_135596180 | 3.16 |
ENST00000283054.4
ENST00000392928.1 |
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
| chr2_+_90139056 | 3.16 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr14_+_21423611 | 3.15 |
ENST00000304625.2
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) |
| chr4_+_56815102 | 3.13 |
ENST00000257287.4
|
CEP135
|
centrosomal protein 135kDa |
| chr14_+_22386325 | 3.10 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
| chr2_+_135596106 | 3.09 |
ENST00000356140.5
|
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
| chr6_-_25874440 | 3.09 |
ENST00000361703.6
ENST00000397060.4 |
SLC17A3
|
solute carrier family 17 (organic anion transporter), member 3 |
| chr2_-_89278535 | 3.07 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr22_+_39353527 | 3.06 |
ENST00000249116.2
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A |
| chr7_-_38289173 | 3.06 |
ENST00000436911.2
|
TRGC2
|
T cell receptor gamma constant 2 |
| chr19_-_14785622 | 3.05 |
ENST00000443157.2
|
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
| chr12_+_113344755 | 3.05 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
| chr1_+_207669495 | 3.03 |
ENST00000367052.1
ENST00000367051.1 ENST00000367053.1 |
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group) |
| chr17_-_38721711 | 3.02 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
| chr2_+_90121477 | 3.02 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
| chr14_+_22475742 | 3.01 |
ENST00000390447.3
|
TRAV19
|
T cell receptor alpha variable 19 |
| chr1_-_160549235 | 2.99 |
ENST00000368054.3
ENST00000368048.3 ENST00000311224.4 ENST00000368051.3 ENST00000534968.1 |
CD84
|
CD84 molecule |
| chr12_-_10282742 | 2.98 |
ENST00000298523.5
ENST00000396484.2 ENST00000310002.4 |
CLEC7A
|
C-type lectin domain family 7, member A |
| chr19_-_54824344 | 2.97 |
ENST00000346508.3
ENST00000446712.3 ENST00000432233.3 ENST00000301219.3 |
LILRA5
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
| chr19_+_14693888 | 2.95 |
ENST00000547437.1
ENST00000397439.2 ENST00000417570.1 |
CLEC17A
|
C-type lectin domain family 17, member A |
| chr8_-_17767866 | 2.94 |
ENST00000398056.2
|
FGL1
|
fibrinogen-like 1 |
| chr15_-_80263506 | 2.93 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
| chr12_-_10282836 | 2.93 |
ENST00000304084.8
ENST00000353231.5 ENST00000525605.1 |
CLEC7A
|
C-type lectin domain family 7, member A |
| chr1_+_196946664 | 2.91 |
ENST00000367414.5
|
CFHR5
|
complement factor H-related 5 |
| chr2_+_234590556 | 2.90 |
ENST00000373426.3
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7 |
| chr12_-_10282681 | 2.87 |
ENST00000533022.1
|
CLEC7A
|
C-type lectin domain family 7, member A |
| chr4_-_71532207 | 2.86 |
ENST00000543780.1
ENST00000391614.3 |
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr1_+_158901329 | 2.83 |
ENST00000368140.1
ENST00000368138.3 ENST00000392254.2 ENST00000392252.3 ENST00000368135.4 |
PYHIN1
|
pyrin and HIN domain family, member 1 |
| chr7_-_142139783 | 2.83 |
ENST00000390374.3
|
TRBV7-6
|
T cell receptor beta variable 7-6 |
| chr12_-_96389702 | 2.83 |
ENST00000552509.1
|
HAL
|
histidine ammonia-lyase |
| chr16_-_71323617 | 2.81 |
ENST00000563876.1
|
CMTR2
|
cap methyltransferase 2 |
| chr1_+_196946680 | 2.80 |
ENST00000256785.4
|
CFHR5
|
complement factor H-related 5 |
| chr1_+_225600404 | 2.77 |
ENST00000366845.2
|
AC092811.1
|
AC092811.1 |
| chr6_-_49712123 | 2.76 |
ENST00000263045.4
|
CRISP3
|
cysteine-rich secretory protein 3 |
| chr4_-_70361615 | 2.76 |
ENST00000305107.6
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4 |
| chr16_-_28634874 | 2.76 |
ENST00000395609.1
ENST00000350842.4 |
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
| chr14_-_106926724 | 2.75 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
| chr2_-_89442621 | 2.74 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
| chr7_+_150382781 | 2.74 |
ENST00000223293.5
ENST00000474605.1 |
GIMAP2
|
GTPase, IMAP family member 2 |
| chr19_-_14785674 | 2.73 |
ENST00000253673.5
|
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
| chr16_-_71610985 | 2.73 |
ENST00000355962.4
|
TAT
|
tyrosine aminotransferase |
| chr19_-_58864848 | 2.73 |
ENST00000263100.3
|
A1BG
|
alpha-1-B glycoprotein |
| chr6_-_133084580 | 2.73 |
ENST00000525270.1
ENST00000530536.1 ENST00000524919.1 |
VNN2
|
vanin 2 |
| chr16_+_53412368 | 2.72 |
ENST00000565189.1
|
RP11-44F14.2
|
RP11-44F14.2 |
| chr6_+_123038689 | 2.72 |
ENST00000354275.2
ENST00000368446.1 |
PKIB
|
protein kinase (cAMP-dependent, catalytic) inhibitor beta |
| chr15_-_90358564 | 2.71 |
ENST00000559874.1
|
ANPEP
|
alanyl (membrane) aminopeptidase |
| chr2_+_185463093 | 2.70 |
ENST00000302277.6
|
ZNF804A
|
zinc finger protein 804A |
| chr14_+_22465771 | 2.69 |
ENST00000390445.2
|
TRAV17
|
T cell receptor alpha variable 17 |
| chr17_+_34431212 | 2.69 |
ENST00000394495.1
|
CCL4
|
chemokine (C-C motif) ligand 4 |
| chr12_+_20968608 | 2.68 |
ENST00000381541.3
ENST00000540229.1 ENST00000553473.1 ENST00000554957.1 |
LST3
SLCO1B3
SLCO1B7
|
Putative solute carrier organic anion transporter family member 1B7; Uncharacterized protein solute carrier organic anion transporter family, member 1B3 solute carrier organic anion transporter family, member 1B7 (non-functional) |
| chr6_+_131894284 | 2.67 |
ENST00000368087.3
ENST00000356962.2 |
ARG1
|
arginase 1 |
| chr13_-_30948036 | 2.66 |
ENST00000447147.1
ENST00000444319.1 |
LINC00426
|
long intergenic non-protein coding RNA 426 |
| chr11_-_104827425 | 2.65 |
ENST00000393150.3
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase |
| chr1_+_84630574 | 2.65 |
ENST00000413538.1
ENST00000417530.1 |
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
| chr12_-_92536433 | 2.64 |
ENST00000551563.2
ENST00000546975.1 ENST00000549802.1 |
C12orf79
|
chromosome 12 open reading frame 79 |
| chr2_+_218989991 | 2.63 |
ENST00000453237.1
|
CXCR2
|
chemokine (C-X-C motif) receptor 2 |
| chr2_-_89619904 | 2.62 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
| chr14_-_106994333 | 2.60 |
ENST00000390624.2
|
IGHV3-48
|
immunoglobulin heavy variable 3-48 |
Network of associatons between targets according to the STRING database.
First level regulatory network of DLX4_HOXD8
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.1 | 3.1 | GO:0015747 | urate transport(GO:0015747) |
| 2.4 | 7.3 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 2.4 | 7.2 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 2.3 | 6.9 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 2.0 | 46.8 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 2.0 | 10.1 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 1.9 | 26.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 1.6 | 4.7 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 1.5 | 1.5 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
| 1.5 | 5.8 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 1.4 | 8.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 1.4 | 19.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 1.3 | 2.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 1.3 | 2.7 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 1.3 | 4.0 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 1.3 | 3.8 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 1.3 | 5.0 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 1.3 | 6.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 1.2 | 7.0 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 1.1 | 10.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 1.1 | 3.4 | GO:0070409 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 1.1 | 3.3 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
| 1.1 | 1.1 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 1.1 | 7.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 1.1 | 5.3 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) positive regulation of phospholipid catabolic process(GO:0060697) |
| 1.0 | 5.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 1.0 | 3.0 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 1.0 | 3.0 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) regulation of dendritic cell dendrite assembly(GO:2000547) |
| 1.0 | 14.4 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 1.0 | 3.8 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.9 | 158.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.9 | 2.7 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.9 | 4.3 | GO:0030070 | insulin processing(GO:0030070) |
| 0.9 | 2.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.8 | 2.5 | GO:0002652 | regulation of tolerance induction dependent upon immune response(GO:0002652) |
| 0.8 | 1.7 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.8 | 5.6 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.8 | 5.5 | GO:0050955 | thermoception(GO:0050955) |
| 0.8 | 5.5 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.8 | 2.3 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.8 | 2.3 | GO:1903980 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) positive regulation of microglial cell activation(GO:1903980) |
| 0.8 | 13.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.7 | 3.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.7 | 2.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.7 | 5.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.7 | 2.1 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
| 0.7 | 2.1 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.7 | 12.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
| 0.7 | 2.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.6 | 9.6 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.6 | 1.8 | GO:0070105 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.6 | 1.8 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.6 | 1.8 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.6 | 5.3 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.6 | 1.7 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 0.6 | 2.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.6 | 1.7 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.6 | 1.7 | GO:2000224 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.5 | 1.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.5 | 4.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.5 | 4.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.5 | 2.7 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
| 0.5 | 10.8 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.5 | 1.5 | GO:1903413 | cellular response to bile acid(GO:1903413) response to iron ion starvation(GO:1990641) |
| 0.5 | 3.0 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
| 0.5 | 1.0 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.5 | 4.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.5 | 11.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.5 | 8.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.5 | 4.8 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.5 | 4.8 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.5 | 3.9 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.5 | 1.4 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
| 0.5 | 0.5 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
| 0.5 | 1.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.4 | 8.8 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.4 | 1.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.4 | 3.4 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.4 | 0.4 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
| 0.4 | 2.8 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.4 | 2.0 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.4 | 1.2 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.4 | 1.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.4 | 2.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.4 | 3.1 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.4 | 20.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.4 | 10.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.4 | 1.5 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.4 | 12.0 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.4 | 2.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.4 | 5.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 | 1.8 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.4 | 1.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.3 | 13.6 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.3 | 8.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.3 | 3.1 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.3 | 1.4 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.3 | 5.9 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.3 | 1.4 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.3 | 5.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.3 | 1.0 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
| 0.3 | 64.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.3 | 1.9 | GO:2000537 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.3 | 2.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.3 | 1.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.3 | 3.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.3 | 2.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.3 | 3.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.3 | 3.0 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.3 | 1.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.3 | 0.3 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.3 | 1.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.3 | 2.6 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.3 | 0.6 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.3 | 1.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.3 | 1.6 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.3 | 0.5 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.3 | 5.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.3 | 0.8 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.3 | 1.0 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.3 | 2.0 | GO:0009441 | fatty acid alpha-oxidation(GO:0001561) glycolate metabolic process(GO:0009441) |
| 0.3 | 2.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.3 | 0.8 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.3 | 0.8 | GO:0070839 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.2 | 2.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.2 | 2.4 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 0.2 | 0.7 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
| 0.2 | 2.6 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 | 1.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.2 | 1.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.2 | 0.9 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 | 1.4 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.2 | 4.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.2 | 1.6 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 0.7 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.2 | 1.4 | GO:0002857 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.2 | 1.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 | 0.9 | GO:0061743 | motor learning(GO:0061743) |
| 0.2 | 0.7 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.2 | 0.4 | GO:0034759 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.2 | 2.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.2 | 4.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.2 | 0.4 | GO:0022411 | cellular component disassembly(GO:0022411) |
| 0.2 | 1.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.2 | 2.5 | GO:0002517 | T cell tolerance induction(GO:0002517) |
| 0.2 | 0.6 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.2 | 7.0 | GO:0019835 | cytolysis(GO:0019835) |
| 0.2 | 2.9 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 0.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.2 | 0.8 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic metaphase/anaphase transition(GO:0030071) metaphase/anaphase transition of cell cycle(GO:0044784) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.2 | 0.6 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.2 | 4.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.2 | 0.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.2 | 1.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.2 | 2.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.2 | 0.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.2 | 15.8 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
| 0.2 | 1.4 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.2 | 1.0 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.2 | 2.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
| 0.2 | 0.6 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.2 | 0.7 | GO:0009804 | coumarin metabolic process(GO:0009804) phenylpropanoid catabolic process(GO:0046271) |
| 0.2 | 1.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.2 | 11.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.2 | 1.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 0.5 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.2 | 0.9 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.2 | 0.9 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.2 | 1.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.2 | 4.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.2 | 13.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.2 | 2.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 0.7 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.2 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.2 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 | 1.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 0.2 | 0.5 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.2 | 0.9 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 0.2 | 0.7 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.2 | 0.8 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.2 | 0.2 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.2 | 6.0 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.2 | 3.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.2 | 1.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.2 | 2.3 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.2 | 0.5 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.2 | 0.2 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.2 | 2.2 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
| 0.2 | 0.5 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.2 | 0.6 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.2 | 0.6 | GO:0060023 | soft palate development(GO:0060023) |
| 0.2 | 0.5 | GO:0051300 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.2 | 0.2 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.2 | 0.8 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.2 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 3.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.2 | 0.5 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.1 | 1.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 | 1.2 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.1 | 0.7 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.1 | 0.4 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 | 0.4 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 | 0.9 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 | 1.9 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.1 | 0.4 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.1 | 4.6 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.1 | 0.4 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.1 | 1.8 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 1.4 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
| 0.1 | 1.1 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.1 | 0.9 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.1 | 0.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 | 1.8 | GO:0050817 | coagulation(GO:0050817) |
| 0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
| 0.1 | 1.0 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.1 | 0.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.1 | 12.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 1.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 | 0.4 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.1 | 3.9 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.1 | 2.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.1 | 0.6 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centriole replication(GO:0046600) |
| 0.1 | 2.0 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.1 | 0.4 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 | 0.4 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 | 3.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.1 | 0.5 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.1 | 1.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.1 | 1.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 1.4 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 | 0.4 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 | 0.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.1 | 1.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.1 | 0.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 1.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.1 | 1.2 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 | 0.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.5 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.1 | 0.6 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.1 | 0.3 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 | 1.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 3.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 | 0.9 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.1 | 2.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 | 2.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.4 | GO:0006868 | glutamine transport(GO:0006868) glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 | 0.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 1.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 0.1 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
| 0.1 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.1 | 1.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 | 0.9 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.1 | 0.6 | GO:0042335 | cuticle development(GO:0042335) |
| 0.1 | 3.5 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.1 | 2.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.1 | 0.6 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 | 3.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 0.3 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.1 | 0.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.1 | 0.6 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
| 0.1 | 1.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 0.3 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 | 0.3 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.1 | 0.6 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 | 1.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.1 | 0.5 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 | 0.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.1 | 1.9 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
| 0.1 | 1.1 | GO:0010212 | response to ionizing radiation(GO:0010212) |
| 0.1 | 0.6 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.1 | 1.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 0.3 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.1 | 0.3 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.1 | 2.5 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 | 0.8 | GO:0051297 | centrosome cycle(GO:0007098) centrosome organization(GO:0051297) |
| 0.1 | 2.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 | 1.3 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.1 | 0.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
| 0.1 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 0.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
| 0.1 | 0.5 | GO:0015744 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) succinate transmembrane transport(GO:0071422) |
| 0.1 | 1.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 | 1.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 1.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.1 | 0.5 | GO:0006581 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.1 | 0.3 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.1 | 4.1 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.1 | 1.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 | 0.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.1 | 0.9 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.1 | 1.2 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 0.2 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.1 | 13.2 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 0.4 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 1.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 1.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.1 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 0.2 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.1 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.1 | 0.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.1 | 0.3 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 | 0.7 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.1 | 0.6 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.1 | 0.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 0.7 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 | 0.2 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) RNA repair(GO:0042245) |
| 0.1 | 0.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 | 1.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 0.6 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.1 | 0.4 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.1 | 0.9 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 | 0.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.1 | 1.5 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 | 1.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 3.9 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 5.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 0.9 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.1 | 1.2 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 2.4 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.1 | 0.7 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.1 | 0.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.1 | 0.3 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 0.7 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
| 0.1 | 1.7 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.1 | 0.9 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.1 | 0.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 | 1.3 | GO:0071467 | cellular response to pH(GO:0071467) |
| 0.1 | 0.3 | GO:0070942 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.1 | 0.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.1 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.1 | 1.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 0.3 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.1 | 0.6 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.1 | 0.8 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.1 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 | 0.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 0.9 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
| 0.1 | 1.9 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.1 | 0.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.1 | 1.6 | GO:0009309 | amine biosynthetic process(GO:0009309) |
| 0.1 | 1.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.1 | 1.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 0.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
| 0.1 | 1.1 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.1 | 0.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 | 2.0 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.1 | 1.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.1 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
| 0.1 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 0.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.1 | 3.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.1 | 0.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 0.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.9 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.1 | 0.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
| 0.1 | 2.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 0.5 | GO:0071674 | mononuclear cell migration(GO:0071674) |
| 0.1 | 1.4 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.1 | 0.3 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
| 0.1 | 0.4 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.1 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 0.8 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 0.1 | GO:0050821 | protein stabilization(GO:0050821) |
| 0.1 | 2.4 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 | 0.3 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 4.1 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.1 | 32.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.1 | 0.4 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.1 | 0.8 | GO:0033189 | response to vitamin A(GO:0033189) |
| 0.0 | 0.8 | GO:0036315 | cellular response to sterol(GO:0036315) |
| 0.0 | 1.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.0 | 0.2 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 | 0.6 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.0 | 1.2 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.0 | 0.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.0 | 0.4 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 | 1.9 | GO:0030155 | regulation of cell adhesion(GO:0030155) |
| 0.0 | 0.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.0 | 1.3 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.0 | 0.9 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 0.2 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.0 | 0.3 | GO:0001755 | neural crest cell migration(GO:0001755) |
| 0.0 | 2.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.0 | 0.6 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.0 | 0.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 | 0.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 | 0.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.0 | 0.5 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.0 | 1.0 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.0 | 3.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 1.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 | 0.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 | 1.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.0 | 0.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.0 | 0.6 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.0 | 0.4 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.0 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.0 | 4.0 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.0 | 0.8 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 | 0.1 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.0 | 0.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.0 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 2.4 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.0 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 | 0.4 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 | 0.1 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.0 | 0.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 0.8 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 0.2 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
| 0.0 | 0.6 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.0 | 0.3 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.0 | 0.8 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.0 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.0 | 0.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 0.1 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.0 | 2.2 | GO:0042113 | B cell activation(GO:0042113) |
| 0.0 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.0 | 1.0 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.0 | 3.0 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
| 0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.0 | 1.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 | 0.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.0 | 1.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.0 | 3.2 |